Voyager Therapeutics, Inc. (VYGR) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.04 | -80.5% |
| 2024 | $-1.13 | -138.0% |
| 2023 | $2.97 | +345.5% |
| 2022 | $-1.21 | +36.0% |
| 2021 | $-1.89 | -292.9% |
| 2020 | $0.98 | +181.0% |
| 2019 | $-1.21 | +56.0% |
| 2018 | $-2.75 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.04 | -80.5% |
| 2024 | $-1.13 | -138.0% |
| 2023 | $2.97 | +345.5% |
| 2022 | $-1.21 | +36.0% |
| 2021 | $-1.89 | -292.9% |
| 2020 | $0.98 | +181.0% |
| 2019 | $-1.21 | +56.0% |
| 2018 | $-2.75 | — |